Loading stock data…
HSIC
$81.25+1.03 (+1.28%)
Pre-Market$81.82+0.57 (+0.70%)· Last close Jun 12
Henry Schein, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Henry Schein, Inc. in the Healthcare sector is trading at $81.25. Wall Street consensus targets $88.07 (15 analysts), implying a +8.4% move over the next 12 months. The stock is currently 9% below its 52-week high of $89.29, remaining 10.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +8.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.37B↓ | $3.44B↑ | $3.34B↑ | $3.24B↑ | $3.17B |
| Gross Profit | $1.07B↑ | $1.06B↑ | $1.03B↑ | $1.02B↑ | $1.00B |
| Operating Income | $194.00M↑ | $186.00M↓ | $198.00M↑ | $174.00M↓ | $200.00M |
| Net Income | $107.00M↑ | $101.00M | $101.00M↑ | $86.00M↓ | $110.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.09%
Volume
Today's trading volume
1.12M
Recent News
How Investors Are Reacting To Henry Schein (HSIC) Upgrade On Dental Strength And Margin Improvements
Earlier this week, BTIG upgraded Henry Schein’s rating, highlighting strong performance in its dental segment and improved profit margins from recent cost-saving efforts. The firm’s commentary suggests that efficiency gains in Henry Schein’s core operations are becoming a more important driver of its overall business profile. We’ll now explore how BTIG’s upgrade, centered on margin improvement and dental strength, may influence Henry Schein’s existing investment narrative. The future of work...
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the last week. The “Buy the Dip” traders come in, briefly get an uptick, and a move higher, and the sellers swarm in to ... Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
M.D. Sass Exits Sallie Mae -- Selling Its Entire $33.1 Million Stake
SLM Corporation, commonly known as Sallie Mae, is the leading provider of private student loans in the United States.
Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.